Skip directly to content

Improving Patient Care in Tobacco Dependency

Pfizer is now inviting applications from Healthcare Organisations such as CCGs, Health Boards, GP Federations or Hospital Trusts for Medical and Educational Goods and Services (MEGS) to support Improvements in Patient Care in Tobacco Dependency.


In this competitive grant programme, we are particularly interested in receiving proposals that fulfil any of the following criteria:

  • Enhance or establish patient access to tobacco dependency support in general practice and secondary care through innovative approaches
  • Provide an educational legacy to support continued management of tobacco dependency as a priority for general practice

Applications must be in line with national guidance for smoking cessation/tobacco dependency.

Proposals for projects covering the following areas are out of scope of this call:

  • Projects bearing the name of specific medicines (medicines should only be referred to by class)
  • Projects designed to increase the uptake of a single therapeutic agent or intervention (projects should be aimed at improving adherence to specific guidelines or patient pathways)
  • Projects that are in scope of one of Pfizer’s other Smoking Cessation MEGS programmes
    • Quit @ Work
    • Enhance in Practice
  • Applications for funding of services which should be provided as standard within the NHS
  • Interventional or observational clinical studies
  • In vitro or in vivo (animal) studies
  • Non-interventional studies, such as epidemiological studies
  • Outcomes research studies where the primary focus is to understand the results of particular healthcare practices and interventions as well as to monitor and improve the quality of care
  • Other types of independent research on disease states, including novel diagnostic screening tools and surveys

Please see the Call for IPCTD Grant Overview for full details of the scope of this call. If you would like to submit an application please download and complete the Grant Application Form. Once you have completed the application form please select apply for IPCTD Grant  - this will launch the online Pfizer Grants Management System where completed application forms should be submitted.

The deadline for submission is 12 April 2018 and applications will be reviewed in April 2018 to evaluate and select the best proposals.

To contact Pfizer for any other purpose, including adverse event reports, medical information requests, or data protection enquiries please call 01304 616161

PP-GIP-GBR-3096 / January 2018